Research Article

Idiopathic granulomatous mastitis: factors influencing recovery and recurrence

Volume: 5 Number: 5 September 4, 2019
EN

Idiopathic granulomatous mastitis: factors influencing recovery and recurrence

Abstract

Objectives: Idiopathic granulomatous mastitis (IGM) is an idiopathic, inflammatory, and benign disease of the breast. The aim of this study was to determine possible risk factors for the recurrence of IGM in patients treated with different treatment modalities.

Methods: It was planned to explore the risk factors of the disease through the evaluation of the medical records of 81 patients with the relevant diagnosis in the archives of Hacettepe University. The medical records of the patients were retrospectively screened for information regarding age, sex, total number of pregnancies, duration of breastfeeding, rheumatologic diseases, size and recurrence of the radiologically detected lesions. The results of two-year follow-up of the patients after the treatment were evaluated. The rates of recovery and recurrence after the treatment were determined for patients who received antibiotic therapy alone, who underwent wide excision alone, who received antibiotic therapy in combination with steroid therapy, and who received added azathioprine and/or methotrexate therapy.

Results: No significant difference was observed between 12 patients having recurrence and 69 patients having no recurrence. However, the recovery time was shorter for patients with a lesion size of ≤ 20 mm who underwent wide excision or received antibiotic therapy alone.

Conclusion: Among patients with a mass size ≤ 20 mm, those treated with wide excision and antibiotic therapy alone had shorter recovery times compared with those who received immunosuppressive therapy. In addition, it may take more than two years to terminate the treatment in patients who received medical treatment alone.

Keywords

References

  1. [1] Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol 1972;58:642-6.
  2. [2] Baslaim MM, Khayat HA, Al-Amoudi SA. Idiopathic granulomatous mastitis: A heterogeneous disease with variable clinical presentation. World J Surg 2007;31:1677-81.
  3. [3] Ozel L, Unal A, Unal E, Kara M, Erdoğdu E, Krand O, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today 2012;42:729-33.
  4. [4] Taylor GB, Paviour SD, Musaad S, Jones WO, Holland DJ. A clinicopathological review of 34 cases of inflammatory breast disease showing an association between corynebacteria infection and granulomatous mastitis. Pathology 2003;35:109-19.
  5. [5] Akcan A, Akyildiz H, Deneme MA, Akgun H, Aritas Y. Granulomatous lobular mastitis: A complex diagnostic and therapeutic problem. World J Surg 2006;30:1403-9.
  6. [6] Hugon-Rodin J, Plu-Bureau G, Hugol D, Gompel A. Management of granulomatous mastitis: a series of 14 patients. Gynecol Endocrinol 2012;28:921-4.
  7. [7] Raj N, Macmillan RD, Ellis IO, Deighton CM. Rheumatologists and breasts: immunosuppressive therapy for granulomatous mastitis. Rheumatology 2004;43:1055-6.
  8. [8] Kim j, Tymms KE, Buckingham JM. Methotrexate in the management of granulomatous mastitis. ANZ J Surg 2003;73:247-9.

Details

Primary Language

English

Subjects

Surgery , Pathology

Journal Section

Research Article

Publication Date

September 4, 2019

Submission Date

May 16, 2018

Acceptance Date

November 14, 2018

Published in Issue

Year 2019 Volume: 5 Number: 5

AMA
1.Aydın HO, Baykal A, Konan A, Kaynaroğlu V. Idiopathic granulomatous mastitis: factors influencing recovery and recurrence. Eur Res J. 2019;5(5):768-775. doi:10.18621/eurj.424016

Cited By